Loading data for LIPO — first visit, this takes a few seconds.
Lipella Pharmaceuticals I... (LIPO)
OTC Markets OTCPK: LIPO
· 실시간 가격 · USD
0.00
n/a (n/a)
종가 기준: Aug 18, 2026, 8:00 PM
Lipella Pharmaceuticals Inc. (LIPO) Stock Price, Analysis & Data
데이터 없음
LIPO 소개
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrol...
전체 기업 정보재무 실적
2024년 Lipella Pharmaceuticals의 매출은 536.36K로, 전년 449.62K 대비 19.29% 증가했습니다. 순이익은 -5.02M로, 8.6% 증가했습니다.
재무제표어닝 서프라이즈
Lipella Pharmaceuticals가 Mar 28, 2025에 분기 실적을 발표했습니다:
